Clicky

PetIQ, Inc.(PETQ)

Description: PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.


Keywords: Medicine Drugs Pain Diabetes Retail Store Antibiotics Arthritis Control Products Wellness Products Insecticide Wellness Dog E Commerce Channels Rheumatology Rimadyl

Home Page: petiq.com

PETQ Technical Analysis

230 East Riverside Drive
Eagle, ID 83616
United States
Phone: 208 939 8900


Officers

Name Title
Mr. McCord Christensen Chairman & CEO
Mr. Michael A. Smith Pres & COO
Mr. Robert Michael Herrman Exec. VP, Gen. Counsel & Corp. Sec.
Mr. Zvi Glasman Chief Financial Officer
Mr. John Pearson Sr. VP & Head of Services Division

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 7.776
Trailing PE: 0
Price-to-Book MRQ: 1.5409
Price-to-Sales TTM: 0.3449
IPO Date: 2017-07-21
Fiscal Year End: December
Full Time Employees: 849
Back to stocks